To include your compound in the COVID-19 Resource Center, submit it here.
Allergan plc (NYSE:AGN) reported 3Q15 earnings and licensed dry eye candidate tavilermide ( MIM-D3) from Mimetogen Pharmaceuticals Inc. (Montreal, Quebec). Allergan did not give an update regarding merger
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury